Literature DB >> 21538337

Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency.

Katie C Russell1, Michelle R Lacey, Jennifer K Gilliam, H Alan Tucker, Donald G Phinney, Kim C O'Connor.   

Abstract

Human mesenchymal stem cells (MSCs) from bone marrow are a heterogeneous ensemble of progenitors and lineage-committed cells, with a broad range of regenerative properties. Ex vivo expansion to produce sufficient quantities of MSCs is essential for most therapeutic applications. The present study resolves the relationship between proliferation potential of MSCs and their potency. Clonal analysis generated single-cell derived colonies of MSCs that were classified according to their trilineage potential to exhibit adipo- (A), chondro- (C), and osteogenesis (O) as a measure of potency. Multipotent OAC clones were highly proliferative with colony-forming efficiencies that ranged from 35% to 90%; whereas, O clones formed colonies with an efficiency of 5% or less (P < 0.01). Similar trends were evident during ex vivo expansion: for example, the median specific growth rate was 0.8  day(-1) (20 h doubling time) for cultures inoculated with OAC clones and was 5-fold less for inocula of O clones (P < 0.01). OA and OC clones had similar proliferation potentials. More than 75% of cells in subconfluent cultures inoculated with O clones stained positive for senescence-associated β-galactosidase activity vs. less than 10% for OAC clones (P < 0.001). Apoptotic cells were in the minority for all potency groups. Preliminary data generated during clonal analysis suggest that osteogenic potential of MSCs to produce mineralized matrix is a function of potency, as well. These results are discussed in the context of the preparation of efficacious MSC therapies by ex vivo expansion.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21538337      PMCID: PMC3178709          DOI: 10.1002/bit.23193

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  44 in total

1.  Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate.

Authors:  C M Digirolamo; D Stokes; D Colter; D G Phinney; R Class; D J Prockop
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

2.  Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy.

Authors:  A Banfi; A Muraglia; B Dozin; M Mastrogiacomo; R Cancedda; R Quarto
Journal:  Exp Hematol       Date:  2000-06       Impact factor: 3.084

3.  Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells.

Authors:  D C Colter; I Sekiya; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

4.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.

Authors:  Stan Gronthos; Andrew C W Zannettino; Shelley J Hay; Songtao Shi; Stephen E Graves; Angela Kortesidis; Paul J Simmons
Journal:  J Cell Sci       Date:  2003-05-01       Impact factor: 5.285

5.  In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment.

Authors:  Katie C Russell; Donald G Phinney; Michelle R Lacey; Bonnie L Barrilleaux; Kristin E Meyertholen; Kim C O'Connor
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

6.  Is beta-galactosidase staining a marker of senescence in vitro and in vivo?

Authors:  J Severino; R G Allen; S Balin; A Balin; V J Cristofalo
Journal:  Exp Cell Res       Date:  2000-05-25       Impact factor: 3.905

7.  Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality.

Authors:  Ichiro Sekiya; Benjamin L Larson; Jason R Smith; Radhika Pochampally; Jian-Guo Cui; Darwin J Prockop
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

8.  Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies.

Authors:  Isabelle Barbosa; Stéphanie Garcia; Véronique Barbier-Chassefière; Jean-Pierre Caruelle; Isabelle Martelly; Dulce Papy-García
Journal:  Glycobiology       Date:  2003-05-28       Impact factor: 4.313

Review 9.  Bone marrow stromal stem cells: nature, biology, and potential applications.

Authors:  P Bianco; M Riminucci; S Gronthos; P G Robey
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

10.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  40 in total

1.  Non-adherent mesenchymal progenitors from adipose tissue stromal vascular fraction.

Authors:  Arne Mehrkens; Nunzia Di Maggio; Sinan Gueven; Dirk Schaefer; Arnaud Scherberich; Andrea Banfi; Ivan Martin
Journal:  Tissue Eng Part A       Date:  2013-12-11       Impact factor: 3.845

2.  Survival of aging CD264+ and CD264- populations of human bone marrow mesenchymal stem cells is independent of colony-forming efficiency.

Authors:  Sean D Madsen; Sean H Jones; H Alan Tucker; Margaret K Giler; Dyllan C Muller; Carson T Discher; Katie C Russell; Georgina L Dobek; Mimi C Sammarco; Bruce A Bunnell; Kim C O'Connor
Journal:  Biotechnol Bioeng       Date:  2019-11-12       Impact factor: 4.530

Review 3.  Mesenchymal stem cells and the embryonic reawakening theory of BPH.

Authors:  W Nathaniel Brennen; John T Isaacs
Journal:  Nat Rev Urol       Date:  2018-11       Impact factor: 14.432

4.  Murine embryonic fibroblast cell lines differentiate into three mesenchymal lineages to different extents: new models to investigate differentiation processes.

Authors:  Khaled Dastagir; Kerstin Reimers; Andrea Lazaridis; Sabrina Jahn; Viktor Maurer; Sarah Strauß; Nadjib Dastagir; Christine Radtke; Andreas Kampmann; Vesna Bucan; Peter M Vogt
Journal:  Cell Reprogram       Date:  2014-08       Impact factor: 1.987

5.  αSMA Expression in Large Colonies of Colony-Forming Units-Fibroblast as an Early Predictor of Bone Marrow MSC Expandability.

Authors:  Irina Aizman; William S Holland; Cher Yang; Damien Bates
Journal:  Cell Med       Date:  2016-10-06

Review 6.  Mesenchymal stem cells: Potential role in corneal wound repair and transplantation.

Authors:  Fei Li; Shao-Zhen Zhao
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

7.  Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissue.

Authors:  Maha A Qadan; Nicolas S Piuzzi; Cynthia Boehm; Wesley Bova; Malcolm Moos; Ronald J Midura; Vincent C Hascall; Christopher Malcuit; George F Muschler
Journal:  Cytotherapy       Date:  2018-02-01       Impact factor: 5.414

8.  Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells.

Authors:  Katie C Russell; H Alan Tucker; Bruce A Bunnell; Michael Andreeff; Wendy Schober; Andrew S Gaynor; Karen L Strickler; Shuwen Lin; Michelle R Lacey; Kim C O'Connor
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

9.  Regulation of trachebronchial tissue-specific stem cell pool size.

Authors:  Moumita Ghosh; Russell W Smith; Christine M Runkle; Douglas A Hicks; Karen M Helm; Susan D Reynolds
Journal:  Stem Cells       Date:  2013-12       Impact factor: 6.277

10.  Comparison of human adipose-derived stem cells isolated from subcutaneous, omental, and intrathoracic adipose tissue depots for regenerative applications.

Authors:  Valerio Russo; Claire Yu; Paul Belliveau; Andrew Hamilton; Lauren E Flynn
Journal:  Stem Cells Transl Med       Date:  2013-12-20       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.